SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
1.66
-0.04 (-2.35%)
At close: Jun 17, 2025, 3:03 PM
SAB Biotherapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
11
Upside
562.65
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Chardan Capital | Buy | Maintains | 20 20 | 1104.82% | May 15, 2025 | |
| HC Wainwright & Co. | Buy | Assumes | 10 | 502.41% | May 14, 2025 | |
| Chardan Capital | Buy | Maintains | 25 20 | 1104.82% | Apr 1, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.